BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31176960)

  • 1. Incidence of skeletal-related events in patients with breast or prostate cancer-induced bone metastasis or multiple myeloma: A 12-year longitudinal nationwide healthcare database study.
    Baek YH; Jeon HL; Oh IS; Yang H; Park J; Shin JY
    Cancer Epidemiol; 2019 Aug; 61():104-110. PubMed ID: 31176960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Payer costs for inpatient treatment of pathologic fracture, surgery to bone, and spinal cord compression among patients with multiple myeloma or bone metastasis secondary to prostate or breast cancer.
    Barlev A; Song X; Ivanov B; Setty V; Chung K
    J Manag Care Pharm; 2010; 16(9):693-702. PubMed ID: 21067255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid and skeletal-related events in patients with bone metastatic cancer or multiple myeloma.
    Jeon HL; Oh IS; Baek YH; Yang H; Park J; Hong S; Shin JY
    J Bone Miner Metab; 2020 Mar; 38(2):254-263. PubMed ID: 31673791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health resource utilization associated with skeletal-related events: results from a retrospective European study.
    Body JJ; Pereira J; Sleeboom H; Maniadakis N; Terpos E; Acklin YP; Finek J; Gunther O; Hechmati G; Mossman T; Costa L; Rogowski W; Nahi H; von Moos R
    Eur J Health Econ; 2016 Jul; 17(6):711-21. PubMed ID: 26253584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems.
    Oster G; Lamerato L; Glass AG; Richert-Boe KE; Lopez A; Chung K; Richhariya A; Dodge T; Wolff GG; Balakumaran A; Edelsberg J
    Support Care Cancer; 2013 Dec; 21(12):3279-86. PubMed ID: 23884473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastasis and skeletal-related events in patients with solid cancer: A Korean nationwide health insurance database study.
    Hong S; Youk T; Lee SJ; Kim KM; Vajdic CM
    PLoS One; 2020; 15(7):e0234927. PubMed ID: 32678818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.
    Jensen AØ; Jacobsen JB; Nørgaard M; Yong M; Fryzek JP; Sørensen HT
    BMC Cancer; 2011 Jan; 11():29. PubMed ID: 21261987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.
    Aly A; Onukwugha E; Woods C; Mullins CD; Kwok Y; Qian Y; Arellano J; Balakumaran A; Hussain A
    BMC Med Res Methodol; 2015 Aug; 15():65. PubMed ID: 26286392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study.
    Cetin K; Christiansen CF; Jacobsen JB; Nørgaard M; Sørensen HT
    Lung Cancer; 2014 Nov; 86(2):247-54. PubMed ID: 25240518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.
    Tanaka R; Yonemori K; Hirakawa A; Kinoshita F; Takahashi N; Hashimoto J; Kodaira M; Yamamoto H; Yunokawa M; Shimizu C; Fujimoto M; Fujiwara Y; Tamura K
    Oncologist; 2016 Apr; 21(4):508-13. PubMed ID: 26975863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone.
    McDougall JA; Bansal A; Goulart BH; McCune JS; Karnopp A; Fedorenko C; Greenlee S; Valderrama A; Sullivan SD; Ramsey SD
    Oncologist; 2016 Mar; 21(3):320-6. PubMed ID: 26865591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting.
    Trinkaus M; Simmons C; Myers J; Dranatisaris G; Clemons M
    Support Care Cancer; 2010 Feb; 18(2):197-203. PubMed ID: 19424729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
    Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
    Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.
    Hussain A; Aly A; Daniel Mullins C; Qian Y; Arellano J; Onukwugha E
    Cancer Med; 2016 Nov; 5(11):3300-3309. PubMed ID: 27730756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer.
    Klaassen Z; Howard LE; de Hoedt A; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
    Cancer; 2017 May; 123(9):1528-1535. PubMed ID: 28026865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?
    Howard LE; De Hoedt AM; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Terris MK; Divers CH; Valderrama A; Freedland SJ
    Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):380-384. PubMed ID: 27377207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis.
    Adogwa O; Rubio DR; Buchowski JM; D'Souza A; Shlykov MA; Jennings JW
    J Neurosurg Spine; 2022 Jan; 36(1):125-132. PubMed ID: 33254136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.